Back to Authors

Merl, Man Yee

A5078873758 | I4210165192

Mayo Clinic

Smilow Cancer Hospital

Citations 2

Feasibility and safety of outpatient hypomethylating agent and venetoclax initiation with and without ramp-up for newly diagnosed acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

Leukemia & Lymphoma | April 28, 2025 | Volume: 66 | Issue: 9 | Pages: 1735-1739

10.1080/10428194.2025.2496339 | PMID 40294060

Feasibility and Safety of Outpatient Hypomethylating Agent (HMA) + Venetoclax (Ven) Initiation +/- Ramp-up for Patients (pts) with Newly-Diagnosed Acute Myeloid Leukemia (AML)

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 8921-8922

10.1182/blood-2022-165446